v3.26.1
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Comprehensive Income
Retained Earnings
Total
Equity Balance, value at Dec. 31, 2024 $ 36 $ 593 $ (11,908) $ 129,302 $ 117,427
Equity Balance, shares at Dec. 31, 2024 3,335        
Common stock received and retired upon exercise of stock options $ 0 0 0 0 0
Stock option compensation expense 0 82 0 0 82
Common stock purchased and retired $ (1) (82) 0 (3,138) (3,221)
Common stock purchased and retired, shares (54)        
Foreign currency translation adjustment $ 0 0 718 0 718
Common stock dividends 0 0 0 (1,001) (1,001)
Net income 0 0 0 3,041 3,041
Equity Balance, value at Mar. 31, 2025 $ 33 0 (11,190) 128,204 117,047
Equity Balance, shares at Mar. 31, 2025 3,281        
Equity Balance, value at Dec. 31, 2024 $ 36 593 (11,908) 129,302 117,427
Equity Balance, shares at Dec. 31, 2024 3,335        
Foreign currency translation adjustment         2,546
Net income         6,089
Equity Balance, value at Jun. 30, 2025 $ 32 0 (9,362) 128,862 117,533
Equity Balance, shares at Jun. 30, 2025 3,216        
Equity Balance, value at Mar. 31, 2025 $ 33 0 (11,190) 128,204 117,047
Equity Balance, shares at Mar. 31, 2025 3,281        
Common stock received and retired upon exercise of stock options $ 0 0 0 0 0
Stock option compensation expense 0 86 0 0 86
Common stock purchased and retired $ (1) (86) 0 (3,402) (3,488)
Common stock purchased and retired, shares (65)        
Foreign currency translation adjustment $ 0 0 1,828 0 1,828
Common stock dividends 0 0 0 (988) (988)
Net income 0 0 0 3,048 3,048
Equity Balance, value at Jun. 30, 2025 $ 32 0 (9,362) 128,862 117,533
Equity Balance, shares at Jun. 30, 2025 3,216        
Equity Balance, value at Dec. 31, 2025 $ 32 0 (9,416) 128,652 119,268
Equity Balance, shares at Dec. 31, 2025 3,186        
Stock option compensation expense $ 0 120 0 0 120
Common stock purchased and retired $ 0 (120) 0 (8) (128)
Common stock purchased and retired, shares (2)        
Foreign currency translation adjustment $ 0 0 (503) 0 (503)
Common stock dividends 0 0 0 (987) (987)
Net income 0 0 0 2,604 2,604
Equity Balance, value at Mar. 31, 2026 $ 32 0 (9,919) 130,260 120,373
Equity Balance, shares at Mar. 31, 2026 3,184        
Equity Balance, value at Dec. 31, 2025 $ 32 0 (9,416) 128,652 119,268
Equity Balance, shares at Dec. 31, 2025 3,186        
Foreign currency translation adjustment         (536)
Net income         5,290
Equity Balance, value at Jun. 30, 2026 $ 32 0 (9,952) 131,954 122,034
Equity Balance, shares at Jun. 30, 2026 3,183        
Equity Balance, value at Mar. 31, 2026 $ 32 0 (9,919) 130,260 120,373
Equity Balance, shares at Mar. 31, 2026 3,184        
Stock option compensation expense $ 0 72 0 0 72
Common stock purchased and retired $ 0 (72) 0 (5) (77)
Common stock purchased and retired, shares (1)        
Foreign currency translation adjustment $ 0 0 (34) 0 (34)
Common stock dividends 0 0 0 (987) (987)
Net income 0 0 0 2,686 2,686
Equity Balance, value at Jun. 30, 2026 $ 32 $ 0 $ (9,952) $ 131,954 $ 122,034
Equity Balance, shares at Jun. 30, 2026 3,183